Clinical Trial Update: University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating suramin for autism spectrum disorders conducted by UCSD; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorders

Drugs mentioned

• Suramin (suramin)

Snippet

Sponsor: University of California, San Diego | Conditions: Autism Spectrum Disorders | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-07-16